Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acitretin and Vemurafenib in Advanced Melanoma
NCT02050321Phase 2Terminated
- Sponsor
- University of Arizona
- Start
- Dec 2013
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of acitretin in melanoma, sponsored by University of Arizona. Started Dec 2013; status: terminated.
02
Drugs
acitretin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02050321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02050321.